1. Home
  2. UGRO vs VRAX Comparison

UGRO vs VRAX Comparison

Compare UGRO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$0.31

Market Cap

3.0M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.45

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
VRAX
Founded
2014
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
UGRO
VRAX
Price
$0.31
$0.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$3.00
AVG Volume (30 Days)
3.0M
15.3M
Earning Date
03-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,985,138.00
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
$28.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.35
52 Week High
$1.26
$3.20

Technical Indicators

Market Signals
Indicator
UGRO
VRAX
Relative Strength Index (RSI) 58.69 45.67
Support Level $0.23 $0.43
Resistance Level $0.25 $0.87
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.00
Stochastic Oscillator 49.57 16.11

Price Performance

Historical Comparison
UGRO
VRAX

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: